The expanding role of prodrugs in contemporary drug design and development
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The expanding role of prodrugs in contemporary drug design and development
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-27
DOI
10.1038/nrd.2018.46
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prodrug strategy for cancer cell-specific targeting: A recent overview
- (2017) Xian Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
- (2017) Axel Bräuer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prodrugs – Recent approvals and a glimpse of the pipeline
- (2017) Jarkko Rautio et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunotherapy for head and neck cancer: the future of treatment?
- (2017) Xiujie Xie et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Reaction phenotyping to assess victim drug-drug interaction risks
- (2017) Li Di Expert Opinion on Drug Discovery
- Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
- (2017) Nicholas A. Meanwell et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro – In Vivo Extrapolation of Intestinal Availability for Carboxylesterase Substrates Using Portal Vein–Cannulated Monkey
- (2017) Patrick E. Trapa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
- (2017) Dimitri E. Grigoriadis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children
- (2016) V. Lukacova et al. AAPS Journal
- Proteases in cancer drug delivery
- (2016) Jennifer Vandooren et al. ADVANCED DRUG DELIVERY REVIEWS
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
- (2016) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- Selexipag: First Global Approval
- (2016) Lesley J. Scott DRUGS
- Lisdexamfetamine: A pharmacokinetic review
- (2016) Eloisa Comiran et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The codrug approach for facilitating drug delivery and bioactivity
- (2016) Ibrahim A. Aljuffali et al. Expert Opinion on Drug Delivery
- Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates
- (2016) Peter J. Thornton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
- (2016) N. Gobeau et al. PHARMACEUTICAL RESEARCH
- Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
- (2016) Ralf A. Linker et al. Therapeutic Advances in Chronic Disease
- Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
- (2015) Jessica R. McCombs et al. AAPS Journal
- Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors
- (2015) Gabriel Birkus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
- (2015) Brian J. Kirby et al. CLINICAL PHARMACOKINETICS
- Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension
- (2015) Sheridan M. Hoy DRUGS
- Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: In vitro, rat in situ and human in vivo studies
- (2015) Jef Stappaerts et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension
- (2015) Tetsuo Asaki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
- (2015) Giulio Casi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes
- (2015) Hao Xu et al. MOLECULAR PHARMACEUTICS
- NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
- (2015) Christopher F. O'Brien et al. MOVEMENT DISORDERS
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
- (2015) X Wang et al. PHARMACOGENOMICS JOURNAL
- Gene-Directed Enzyme Prodrug Therapy
- (2014) Jin Zhang et al. AAPS Journal
- Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
- (2014) Ugo Pradere et al. CHEMICAL REVIEWS
- Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
- (2014) Zhe-Yi Hu et al. CLINICAL PHARMACOKINETICS
- Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery
- (2014) Peter Timmins et al. DRUG DISCOVERY TODAY
- Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
- (2014) Magdalena Slusarczyk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative Assessment of Intestinal First-pass Metabolism of Oral Drugs Using Portal-vein Cannulated Rats
- (2014) Yoshiki Matsuda et al. PHARMACEUTICAL RESEARCH
- Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects
- (2014) Shirin Bruderer et al. PHARMACOLOGY
- Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer
- (2013) Christopher R. Garrett et al. CANCER
- Drug transport via the intestinal peptide transporter PepT1
- (2013) Matthias Brandsch CURRENT OPINION IN PHARMACOLOGY
- Chemistry-enabled drug delivery (prodrugs): recent progress and challenges
- (2013) Sophie-Dorothee Clas et al. DRUG DISCOVERY TODAY
- Cytochrome P450-activated prodrugs
- (2013) Paul R Ortiz de Montellano Future Medicinal Chemistry
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug
- (2013) Jonathan Brown et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
- (2013) S. Casey Laizure et al. PHARMACOTHERAPY
- The Discovery of Dabigatran Etexilate
- (2013) Joanne van Ryn et al. Frontiers in Pharmacology
- Glutathione Transferase (GST)-Activated Prodrugs
- (2013) Paolo Ruzza et al. Pharmaceutics
- Polymer therapeutics-prospects for 21st century: The end of the beginning
- (2012) Ruth Duncan et al. ADVANCED DRUG DELIVERY REVIEWS
- Amino acids as promoieties in prodrug design and development
- (2012) Balvinder S. Vig et al. ADVANCED DRUG DELIVERY REVIEWS
- Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
- (2012) Jonathan R. Fromm et al. Clinical Lymphoma Myeloma & Leukemia
- Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
- (2012) Li Di et al. DRUG DISCOVERY TODAY
- Dabigatran Etexilate
- (2012) Celeste B. Burness et al. DRUGS
- Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil
- (2012) Ritu Lal et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects
- (2012) R. E. Nettles et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)
- (2012) John F. Kadow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Species Difference of Esterase Expression and Hydrolase Activity in Plasma
- (2012) Fatma Goksin Bahar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico–in vivo extrapolation and physiologically-based pharmacokinetic modeling approach
- (2012) Jonas Malmborg et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
- (2011) Belinda S. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661
- (2011) Phillip A. Furman et al. ANTIVIRAL RESEARCH
- Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
- (2011) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs
- (2011) Teruko Imai et al. CURRENT DRUG METABOLISM
- Polymer therapeutics as nanomedicines: new perspectives
- (2011) Ruth Duncan CURRENT OPINION IN BIOTECHNOLOGY
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Rational Design and Development of Colon-Specific Prodrugs
- (2011) Suneela S. Dhaneshwar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Bridging solubility between drug discovery and development
- (2011) Li Di et al. DRUG DISCOVERY TODAY
- Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human
- (2011) E. T. Williams et al. DRUG METABOLISM AND DISPOSITION
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Use of Enzyme Inhibitors to Evaluate the Conversion Pathways of Ester and Amide Prodrugs: A Case Study Example with the Prodrug Ceftobiprole Medocaril
- (2011) Gary Eichenbaum et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
- (2011) B. S. Tan et al. MOLECULAR CANCER THERAPEUTICS
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Prodrugs--from Serendipity to Rational Design
- (2011) K. M. Huttunen et al. PHARMACOLOGICAL REVIEWS
- Enzyme-mediated hydrolytic activation of prodrugs
- (2011) Yan-hui Yang et al. Acta Pharmaceutica Sinica B
- PSI-7851, a Pronucleotide of -D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
- (2010) A. M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists
- (2010) S. Jana et al. CURRENT MEDICINAL CHEMISTRY
- Fospropofol
- (2010) Karly P. Garnock-Jones et al. DRUGS
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
- (2010) Eisuke Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prodrugs: Some Thoughts and Current Issues
- (2010) Valentino J. Stella JOURNAL OF PHARMACEUTICAL SCIENCES
- Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2010) Mary E.R. O'Brien et al. Journal of Thoracic Oncology
- Coexistence of passive and carrier-mediated processes in drug transport
- (2010) Kiyohiko Sugano et al. NATURE REVIEWS DRUG DISCOVERY
- Eslicarbazepine Acetate: A Well-Kept Secret?
- (2010) Epilepsy Currents
- Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
- (2010) Pennick Neuropsychiatric Disease and Treatment
- Population-Based Mechanistic Prediction of Oral Drug Absorption
- (2009) Masoud Jamei et al. AAPS Journal
- Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
- (2009) Youcef Mehellou et al. ChemMedChem
- Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers
- (2009) Ritu Lal et al. CLINICAL THERAPEUTICS
- Evaluation of in Vitro Models for Screening Alkaline Phosphatase-Mediated Bioconversion of Phosphate Ester Prodrugs
- (2009) H. Yuan et al. DRUG METABOLISM AND DISPOSITION
- Disposition and Metabolism of a Novel Prostanoid Antiglaucoma Medication, Tafluprost, Following Ocular Administration to Rats
- (2009) Y. Fukano et al. DRUG METABOLISM AND DISPOSITION
- Bimatoprost
- (2009) Monique P. Curran DRUGS & AGING
- Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
- (2009) Seymour INTERNATIONAL JOURNAL OF ONCOLOGY
- Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
- (2009) Paul P Dobesh PHARMACOTHERAPY
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
- (2008) Kristiina Huttunen et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol
- (2008) Hanna Kumpulainen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome
- (2008) Martin C Michel EXPERT OPINION ON PHARMACOTHERAPY
- Your Prodrug Releases Formaldehyde: Should You Be Concerned? No!
- (2008) Sundeep S. Dhareshwar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract
- (2008) Q. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Prodrugs for Amines
- (2008) Ana Simplício et al. MOLECULES
- Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
- (2008) Masakiyo Hosokawa MOLECULES
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases
- (2007) Philip S. Low et al. ACCOUNTS OF CHEMICAL RESEARCH
- Prodrug Strategies in Anticancer Chemotherapy
- (2007) Felix Kratz et al. ChemMedChem
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started